Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$43.21 - $57.6 $500,242 - $666,835
-11,577 Closed
0 $0
Q3 2021

Oct 28, 2021

BUY
$52.8 - $60.32 $88,651 - $101,277
1,679 Added 16.96%
11,577 $644,000
Q2 2021

Aug 10, 2021

BUY
$51.29 - $59.15 $122,429 - $141,191
2,387 Added 31.78%
9,898 $537,000
Q1 2021

Jul 21, 2021

BUY
$42.18 - $56.07 $38,468 - $51,135
912 Added 13.82%
7,511 $421,000
Q4 2020

Feb 12, 2021

BUY
$35.18 - $43.52 $42,216 - $52,224
1,200 Added 22.23%
6,599 $287,000
Q3 2020

Oct 30, 2020

BUY
$37.98 - $48.72 $205,054 - $263,039
5,399 New
5,399 $210,000
Q1 2019

May 13, 2019

SELL
$41.26 - $58.35 $343,035 - $485,121
-8,314 Closed
0 $0
Q4 2018

Feb 05, 2019

BUY
$44.93 - $73.38 $80,244 - $131,056
1,786 Added 27.36%
8,314 $393,000
Q3 2018

Nov 02, 2018

BUY
$56.85 - $80.35 $371,116 - $524,524
6,528 New
6,528 $0

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $539M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.